Sagimet Biosciences Inc.
Sagimet Biosciences Inc.（SGMT）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
sgmt · 股价预测 · 7 位分析师（近3月）· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 7 位华尔街分析师
Buy
7 位分析师
共识
评级分布
12 个月目标价
High
$8.00
Consensus
$8.00
+22.5% upside
Low
$8.00
Median: $8 · Last Close: $6.53
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $6.36 | ↓ 2.61% |
1-day model range: $6.31–$6.41. Peak: $6.41 (-2.61%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $3 | -50.0% |
| 2028 | $2 | -62.5% |
| 2029 | $2 | -67.2% |
| 2030 | $2 | -69.2% |
| 2031 | — | -70.2% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · SGMT · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-19 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-05-04 | Canaccord Genuity | Maintains | Buy→Buy |
| 2026-04-29 | Guggenheim | Maintains | Buy→Buy |
| 2026-03-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-03 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-14 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2025-10-02 | Canaccord Genuity | Maintains | Buy→Buy |
| 2025-06-06 | Jones Trading | Maintains | Buy→Buy |
| 2025-03-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Sagimet Biosciences Inc. (SGMT) stock. Of the recent 29 rating actions, 0 were upgrades and 0 were downgrades. 7 analysts currently cover SGMT.
分析师推荐趋势
SGMT analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 2 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$0M
↓ 99.5% YoY
Revenue Next Year
$8M
↑ 6673.9% YoY
EPS This Year
$-1.20
EPS Next Year
$-1.25
↑ 4.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast SGMT EPS of $-1.20 for the current fiscal year, based on estimates from 7 analysts. The SGMT revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
SGMT 股价预测由两类独立数据源支撑：来自 7 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。SGMT 的共识目标价为 $8.00（+22.5% 上行空间），分析师共识为 Buy。
SGMT 的短期预测（明日）为 $6.36（-2.61%）。 SGMT 对 2027 年的股价预测均值为 $3。 SGMT 对 2030 年的预测区间为 $2–$2。
Sagimet Biosciences Inc. 在 NASDAQ 上市，代码 SGMT。SGMT 在 2027 年的整体展望偏积极，在覆盖分析师中约 86% 对应 Buy 共识。
常见问题
SGMT 预测 · 8 个问题根据 7 位华尔街分析师，SGMT 的 12 个月平均目标价为 $8.00，最高 $8.00、最低 $8.00。若有图表，中位目标价可在上方查看。相对当前价 $6.53，隐含约 +22.5% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.